Neurotech Devices Market - By Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation), Conditions (Epilepsy, Parkinsons Disease, Cognitive Disorder), End-use (Hospital, ASC, Homecare Facility)- Global Forecast, 2023-2032

Description

List of Tables

The global neurotech devices market is expected to witness a CAGR of 13.8% during 2023 and 2032, driven by technological advancements, increasing prevalence of neurological disorders, and ageing population.

According to a report by WHO in 2023, neurological disorders, the second leading global cause of death account for a staggering 9 million annual deaths and are the leading contributors to disability-adjusted life years. With a growing aging population and a rise in chronic neurological conditions, there is an escalating demand for innovative and efficient neurotech solutions. Additionally, the rapid pace of R&D, particularly in neuroimaging and neuromodulation technologies, is propelling the market forward.

The overall neurotech devices market is classified based on product, condition, innovation, end-use, and region.

The neuroprostheses segment is set for decent growth through 2032, driven by advancements in neuroprostheses technology and growing awareness among healthcare providers. These devices are designed to restore lost functions or compensate for disabilities by interfacing directly with the nervous system. The focus on developing more sophisticated and user-friendly neuroprostheses is further expected to open new arenas for growth.

Pain management is expected to witness steady growth during 2023-2032, driven by increasing prevalence of chronic pain conditions and effectiveness of neurotech devices. These devices, including neuromodulators and neurostimulators, are emerging as effective solutions for managing pain. They modulate neural activity, offering relief to patients suffering from conditions such as neuropathic pain or migraines. The growing awareness of non-invasive and drug-free pain management options is fostering the product adoption.

Asia Pacific neurotech devices market is anticipated to witness robust growth through 2032 driven by aging population, increasing healthcare expenditures, and rising awareness about neurological disorders. Governments and healthcare organizations in the nations across the region are investing in infrastructure and research initiatives to support the development and adoption of neurotech devices. The constant technological advancements and collaborations will augment the APAC market growth in the coming years.

Product Code: 4559

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global neurotech devices market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Product type trends
- 2.1.3 Conditions trends
- 2.1.4 End-use trends

Chapter 3 Neurotech Devices Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Rising prevalence of neurological disorders across the globe
  - 3.5.1.2 Technological advancements in neurotech devices
  - 3.5.1.3 Surging number of elderly population base suffering with neurological disorders
  - 3.5.1.4 Increasing awareness and funding in neurotech industry
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Lack of skilled healthcare practitioners
3.6 Growth potential analysis
- 3.6.1 By product type
- 3.6.2 By conditions
- 3.6.3 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 LivaNova PLC
- 4.1.2 Medtronic plc
- 4.1.3 Abbott Laboratories
- 4.1.4 Boston Scientific Corporation
4.2 Competitive analysis of major market players, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic outlook matrix, 2022

Chapter 5 Neurotech Devices Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Neurostimulation
- 5.2.1 Deep brain stimulator
- 5.2.2 Gastric electric stimulator
- 5.2.3 Spinal cord stimulator
- 5.2.4 Sacral nerve stimulator
- 5.2.5 Vagus nerve stimulator
- 5.2.6 Transcutaneous electrical nerve stimulation (TENS)
- 5.2.7 Other neurostimulations
5.3 Neuroprostheses
5.4 Neurosensing
5.5 Neurorehabilitation devices

Chapter 6 Neurotech Devices Market Size and Forecast, By Conditions, 2018-2032 (USD Million)

6.1 Key trends, by conditions
6.2 Pain management
6.3 Cognitive disorders
6.4 Epilepsy
6.5 Urinary and fecal incontinence
6.6 Hearing conditions
6.7 Parkinson's disease
6.8 Depression
6.9 Sleep disorders
6.10 Essential tremor
6.11 Other conditions

Chapter 7 Neurotech Devices Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Homecare facilities
7.5 Other end-users

Chapter 8 Neurotech Devices Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Abbott Laboratories
9.2 Advanced Bionics AG (Sonova)
9.3 Boston Scientific Corporation
9.4 BrainCo, Inc
9.5 Cochlear Limited
9.6 Control Bionics, Inc
9.7 LivaNova PLC
9.8 Medtronic plc
9.9 Nihon Kohden Corporation
9.10 Natus Medical Incorporated
9.11 Integra LifeSciences
9.12 Blackrock Microsystems
9.13 NeuroSigma, Inc.
9.14 NeuroVigil Inc.
9.15 Neuralink Corp.